377 related articles for article (PubMed ID: 21985606)
21. RNA interference induced by siRNAs modified with 4'-thioribonucleosides.
Hoshika S; Minakawa N; Matsuda A
Nucleic Acids Symp Ser (Oxf); 2005; (49):77-8. PubMed ID: 17150641
[TBL] [Abstract][Full Text] [Related]
22. Improving RNA interference in mammalian cells by 4'-thio-modified small interfering RNA (siRNA): effect on siRNA activity and nuclease stability when used in combination with 2'-O-alkyl modifications.
Dande P; Prakash TP; Sioufi N; Gaus H; Jarres R; Berdeja A; Swayze EE; Griffey RH; Bhat B
J Med Chem; 2006 Mar; 49(5):1624-34. PubMed ID: 16509579
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of gene silencing effect and membrane permeability by Peptide-conjugated 27-nucleotide small interfering RNA.
Kubo T; Yanagihara K; Sato Y; Morita Y; Seyama T
Molecules; 2012 Sep; 17(9):11089-102. PubMed ID: 22983148
[TBL] [Abstract][Full Text] [Related]
24. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.
Reich SJ; Fosnot J; Kuroki A; Tang W; Yang X; Maguire AM; Bennett J; Tolentino MJ
Mol Vis; 2003 May; 9():210-6. PubMed ID: 12789138
[TBL] [Abstract][Full Text] [Related]
25. Incorporation of biaryl units into the 5' and 3' ends of sense and antisense strands of siRNA duplexes improves strand selectivity and nuclease resistance.
Yoshikawa K; Ogata A; Matsuda C; Kohara M; Iba H; Kitade Y; Ueno Y
Bioconjug Chem; 2011 Jan; 22(1):42-9. PubMed ID: 21141919
[TBL] [Abstract][Full Text] [Related]
26. Chemical modification of siRNA.
Chernolovskaya EL; Zenkova MA
Curr Opin Mol Ther; 2010 Apr; 12(2):158-67. PubMed ID: 20373259
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of vascular endothelial growth factor gene expression by T7-siRNAs in cultured human retinal pigment epithelial cells.
Li GY; Fan B; Wu YZ; Wang XR; Wang YH; Wu JX
Chin Med J (Engl); 2005 Apr; 118(7):567-73. PubMed ID: 15820087
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of 2'-O-guanidinopropyl-modified nucleoside phosphoramidites and their incorporation into siRNAs targeting hepatitis B virus.
Brzezinska J; D'Onofrio J; Buff MC; Hean J; Ely A; Marimani M; Arbuthnot P; Engels JW
Bioorg Med Chem; 2012 Feb; 20(4):1594-606. PubMed ID: 22264759
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of siRNAs that contain internal variable-length spacer linkages.
Efthymiou TC; Peel B; Huynh V; Desaulniers JP
Bioorg Med Chem Lett; 2012 Sep; 22(17):5590-4. PubMed ID: 22850216
[TBL] [Abstract][Full Text] [Related]
30. Gene silencing efficiency of siRNA-PEG conjugates: effect of PEGylation site and PEG molecular weight.
Jung S; Lee SH; Mok H; Chung HJ; Park TG
J Control Release; 2010 Jun; 144(3):306-13. PubMed ID: 20206653
[TBL] [Abstract][Full Text] [Related]
31. Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing.
Kong F; Liu G; Sun B; Zhou S; Zuo A; Zhao R; Liang D
Int J Pharm; 2012 Jan; 422(1-2):445-53. PubMed ID: 22067703
[TBL] [Abstract][Full Text] [Related]
32. RNA interference induced by siRNAs modified with 4'-thioribonucleosides in cultured mammalian cells.
Hoshika S; Minakawa N; Kamiya H; Harashima H; Matsuda A
FEBS Lett; 2005 Jun; 579(14):3115-8. PubMed ID: 15919084
[TBL] [Abstract][Full Text] [Related]
33. A structure-activity relationship study of siRNAs with structural variations.
Chang CI; Hong SW; Kim S; Lee DK
Biochem Biophys Res Commun; 2007 Aug; 359(4):997-1003. PubMed ID: 17577577
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, RNAi activity and nuclease-resistant properties of apolar carbohydrates siRNA conjugates.
Vengut-Climent E; Terrazas M; Lucas R; Arévalo-Ruiz M; Eritja R; Morales JC
Bioorg Med Chem Lett; 2013 Jul; 23(14):4048-51. PubMed ID: 23764303
[TBL] [Abstract][Full Text] [Related]
35. Effects on RNA interference in gene expression (RNAi) in cultured mammalian cells of mismatches and the introduction of chemical modifications at the 3'-ends of siRNAs.
Hamada M; Ohtsuka T; Kawaida R; Koizumi M; Morita K; Furukawa H; Imanishi T; Miyagishi M; Taira K
Antisense Nucleic Acid Drug Dev; 2002 Oct; 12(5):301-9. PubMed ID: 12477280
[TBL] [Abstract][Full Text] [Related]
36. Dual gene targeted multimeric siRNA for combinatorial gene silencing.
Lee SH; Mok H; Jo S; Hong CA; Park TG
Biomaterials; 2011 Mar; 32(9):2359-68. PubMed ID: 21183215
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of oligonucleotides with glucosamine at the 3'-position and evaluation of their biological activity.
Luo X; Sugiura T; Nakashima R; Kitamura Y; Kitade Y
Bioorg Med Chem Lett; 2013 Jul; 23(14):4157-61. PubMed ID: 23743279
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and properties of novel L-isonucleoside modified oligonucleotides and siRNAs.
Zhang J; Chen Y; Huang Y; Jin HW; Qiao RP; Xing L; Zhang LR; Yang ZJ; Zhang LH
Org Biomol Chem; 2012 Oct; 10(37):7566-77. PubMed ID: 22895883
[TBL] [Abstract][Full Text] [Related]
39. 2'-O-methyl-modified anti-MDR1 fork-siRNA duplexes exhibiting high nuclease resistance and prolonged silencing activity.
Petrova Kruglova NS; Meschaninova MI; Venyaminova AG; Zenkova MA; Vlassov VV; Chernolovskaya EL
Oligonucleotides; 2010 Dec; 20(6):297-308. PubMed ID: 21028964
[TBL] [Abstract][Full Text] [Related]
40. Gene silencing activity of siRNAs with a ribo-difluorotoluyl nucleotide.
Xia J; Noronha A; Toudjarska I; Li F; Akinc A; Braich R; Frank-Kamenetsky M; Rajeev KG; Egli M; Manoharan M
ACS Chem Biol; 2006 Apr; 1(3):176-83. PubMed ID: 17163665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
